# A Study to Compare How Much of the Study Treatment Finerenone Gets Into the Blood When the Same Amount is Taken in One and in Two Tablets of Different Strengths in Healthy Male Participants

> **NCT07116512** · PHASE1 · COMPLETED · sponsor: **Bayer** · enrollment: 60 (actual)

## Conditions studied

- Heart Failure With Left Ventricular Ejection Fraction Greater Than or Equal to 40 Per Cent
- Healthy Volunteers

## Interventions

- **DRUG:** Finerenone (BAY94-8862): intervention A
- **DRUG:** Finerenone (BAY94-8862): intervention B

## Key facts

- **NCT ID:** NCT07116512
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-02
- **Primary completion:** 2023-07-28
- **Final completion:** 2023-07-28
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07116512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07116512, "A Study to Compare How Much of the Study Treatment Finerenone Gets Into the Blood When the Same Amount is Taken in One and in Two Tablets of Different Strengths in Healthy Male Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07116512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*